<!DOCTYPE HTML>
<html lang="en">
<head>
	<meta charset="UTF-8">
	<title>VIKHI</title>
	<link rel="stylesheet" href="css/font-awesome/css/font-awesome.min.css" />

	<link rel="stylesheet" href="css/fonts/stylesheet.css" />
	<link rel="stylesheet" href="css/fonts/fonts.css" />
	<link rel="stylesheet" href="css/bootstrap/bootstrap.min.css" />
	<link rel="stylesheet" href="css/animat/animate.min.css" />
	<link rel="stylesheet" href="css/fancybox/jquery.fancybox.css" />
	<link rel="stylesheet" href="css/nivo-lightbox/nivo-lightbox.css" />
	<link rel="stylesheet" href="css/themes/default/default.css" />
	<link rel="stylesheet" href="css/owl-carousel/owl.carousel.css" />
	<link rel="stylesheet" href="css/owl-carousel/owl.theme.css" />
	<link rel="stylesheet" href="css/owl-carousel/owl.transitions.css">
	<link rel="stylesheet" href="css/style.css" />
	<link rel="stylesheet" href="css/responsive.css" />
	<link href="https://fonts.googleapis.com/css?family=Montserrat|Source+Sans+Pro" rel="stylesheet">
</head>
<body>

	<div class='preloader'><div class='loaded'>&nbsp;</div></div>

	<header id="home" class="header">
		<div class="main_menu_bg navbar-fixed-top">
			<div class="container">
				<div class="row">
					<div class="nave_menu">
					<nav class="navbar navbar-default">
					  <div class="container-fluid">
						<div class="navbar-header">
						  <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false">
						  </button>
						  <a class="navbar-brand" href="index.html">
							<div class="logo">
								<img src="images/vikhiLOGOsm.png" alt="" height="30"/>
							</div>
						  </a>
						</div>

											<div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1">

						  <ul class="nav navbar-nav navbar-right">
							<li><a href="aspectos.html">1. General Aspects</a></li>
							<li><a href="recomendaciones.html">2. Recommendations</a></li>
							<li class="active"><a href="toxicidad00.html">3. Toxicities</a></li>
						  </ul>
						</div>
					  </div>
					</nav>
					</div>
				</div>

			</div>

		</div>
	</header>



	<section class="banner">
		<div class="container">
			<div class="row">
				<div class="main_banner_area text-center">
					<div class="col-md-12 col-sm-12">
						<div class="single_banner_text wow zoomIn" data-wow-duration="1s">
							<h2>Toxicities</h2>
							<br/>
							<div class="separator"></div>
							<h5>BASIC COURSE IN IMMUNOTHERAPY</h5>


						</div>
					</div>
				</div>
			</div>
		</div>
	</section>




	<section class="franja">
	 <div class="overlay_franja">
		 <div class="container">
			 <div class="row">
				 <div class="col-md-12 col-sm-12 col-xs-12">
					 <div class="main_franja_content text-center wow fadeIn" data-wow-duration="2s">
						 <h2>3<span class="negrita">.8</span> OTHER TOXICITIES</h2>
						 <br/>

					 </div>
				 </div>
			 </div>
		 </div>
	 </div>
 </section>




 <section class="texto">
	 <div class="container">
		 <div class="row">
			 <div class="parrafo wow zoomIn" data-wow-duration="0.5s">
				 <h2>Introduction</h2>
				 <br/>
				 <p>Some rare and infrequent immune-mediated toxicities have been described, based on reports of isolated cases.</p>
				 <br/><p>Since the symptoms presented are so rare, attention by the attending physician as well as the patient is required in order to avoid serious adverse events and/or a fatal outcome in these cases. Early clinical management may prevent fatal events.</p>
				 <br/><p>We refer to ocular toxicities (in the form of episcleritis, conjunctivitis and uveitis) described with treatment with Ipilimumab (anti-CTLA-4) in less than 1%.</p>
				 <br/><p>In addition to haematological toxicities (such as autoimmune anaemia, immune-mediated thrombocytopenia and neutropenia, acquired haemophilia A, spinal cord aplasia and disseminated intravascular coagulation) described in less than 4% of cases with anti-TCLA-4 treatment; rheumatological pictures in the form of polymyositis and cardiac issues such as cardiomyositis with anti-PDL-1 and anti-PD-1 treatments (Nivolumab and Pembrolizumab) in less than 2%.</p>
			 </div>
		 </div>
	 </div>
 </section>

	<section class="counterUp">
		<div class="counter_overlay">
			<div class="container">
				<div class="row">
					<div class="main_counter_content text-center">
						<div class="col-md-12 col-sm-12 col-xs-12">

							<img src="images/diagnostico.png" alt="" height="40px"/> <br/><br/>
							<h2>Diagnosis</h2>
							<br/> <br/>
							<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> In the event of <span class="turquesa">ocular toxicity</span>, any changes in visual acuity, blurred vision and red eye...</p>
							<br/>
							<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> In the event of <span class="turquesa">haematological toxicity</span>, any changes in white blood cells, red blood cells or platelets Observed with bleeding in more severe cases.</p>
							<br/>
							<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> In the event of <span class="turquesa">cardiac toxicity</span>, any symptoms of congestive heart failure, acute pulmonary oedema, chest pain, palpitations, arrhythmia, etc.</p>
							<br/>
							<p class="izquierda"><span class="decorado">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span> In the event of <span class="turquesa">rheumatic toxicity</span>, any symptoms of arthralgia and joint stiffness, proximal muscle weakness, asthenia, fever, among others.</p>



						</div>
					</div>
				</div>
			</div>
		</div>
	</section>

	<section class="texto">
		<div class="container">
			<div class="row">
				<div class="parrafo wow zoomIn" data-wow-duration="0.5s">
					<h2>Therapeutic management</h2>
				<br/>
				<p>Monitor the signs and symptoms of each of the toxicities and establish the grade according to the CTCAE version 4.03 (GRADE 0-5).</p>
				<br/>
				<p>In the event of <span class="turquesa">ocular toxicity</span>, any changes in visual acuity, blurred vision, or red eye, intravenous (or equivalent). In refractory cases, the use of immunosuppressants is proposed, such as Cyclosporine, Immunoglobulin and transfusion of blood products. In cases where diagnosis is unclear, bone marrow biopsy is recommended.</p>
				<br/>
				<p>In the case of immune-mediated eye toxicities, the most common symptoms are episcleritis, conjunctivitis and uveitis. Evaluation by an ophthalmology specialist is recommended in any case with topical corticosteroid treatment with 1% prednisolone acetate and a cycloplegic, reserving oral treatment (prednisone 1-2 mg/kg/day orally) for severe cases. The dose should not be reduced until there is an improvement to at least <span class="turquesa">GRADE 1</span> and in a period of no less than 30 days. Treatment should be discontinued in cases of <span class="turquesa">GRADE 3-4</span>.</p>
				<br/>
				<p>In the event of <span class="turquesa">immune-mediated cytopenias</span> it is recommended that treatment be discontinued. With this, the majority regress with the administration of prednisolone 1mg/kg/day. </p>
				<br/>
				<p>In the event of <span class="turquesa">heart toxicities</span> in the form of cardiomyositis, evaluation by a cardiology specialist and intensive medicine specialist is recommended with a biochemical study (creatinine kinase, troponins), echocardiographic study, and immediate initiation of methylprednisolone 1-2 mg/kg/day intravenously is recommended. The majority of these patients present depressions in systolic function and cardio-muscular contractility capacity. Discontinuation of treatment is imperative.</p>
				<br/>




			</div>
		</div>
	</div>
	</section>

	<section class="counterUp">
		<div class="counter_overlay">
			<div class="container">
				<div class="row">
					<div class="main_counter_content text-center">
						<div class="col-md-12 col-sm-12 col-xs-12">




							<br/>

							<div class="contorno wow fadeIn">
							<h2>REMEMBER <span class="negrita">:</span></h2>
							<br/>
							<p><span class="negrita">•</span> It is important to remember that the symptoms presented are non-specific and uncommon, so attention by the attending physician as well as the patient is required in order to avoid serious adverse events and/or a fatal evolution in these cases. Early clinical management may prevent fatal events.</p>
							</div>
						</div>
					</div>
				</div>
			</div>
		</div>
	</section>




	<section>
	 <div class="container">
		 <div class="row">

			 <div class="wedo_content_area">

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contornoActivo wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad01.html"><h4 class="gris">3.1 GASTROINTESTINAL TOX.</h4></a>
						 </div>
					 </div>
				 </div>

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contornoActivo wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad02.html"><h4 class="gris">3.2 PULMONARY TOXICITY</h4></a>
						 </div>
					 </div>
				 </div>

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contornoActivo wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad03.html"><h4 class="gris">3.3 RENAL TOXICITY</h4></a>
						 </div>
					 </div>
				 </div>

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contornoActivo wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad04.html"><h4 class="gris">3.4 LIVER TOXICITY</h4></a>
						 </div>
					 </div>
				 </div>

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contornoActivo wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad05.html"><h4 class="gris">3.5 ENDOCRINE TOXICITY</h4></a>
						 </div>
					 </div>
				 </div>

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contornoActivo wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad06.html"><h4 class="gris">3.6 CUTANEOUS TOXICITY</h4></a>
						 </div>
					 </div>
				 </div>

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contornoActivo wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad07.html"><h4 class="gris">3.7 NEUROLOGICAL TOXICITY</h4></a>
						 </div>
					 </div>
				 </div>

				 <div class="col-md-6 col-sm-6 col-xs-12">
					 <div class="contornoActivo wow fadeIn" data-wow-duration="1s">
						 <div class="single_right_text">
							 <a href="toxicidad08.html"><h4 class="gris">3.8 OTHER TOXICITIES</h4></a>
						 </div>
					 </div>
				 </div>
			 </div>
		 </div>
	 </div>
	</section>


	<footer id="footer" class="footer">
		<div class="container">
			<div class="row">
				<div class="main_footer text-center wow zoomIn" data-wow-duration="1s">
					<p class="centrado"><a href="https://www.e-oncologia.org/"><img src="images/LOGOeonco.png" alt="" height="22px"/></a></p>
				</div>
			</div>
		</div>
	</footer>

	<!-- STRAT SCROLL TO TOP -->

	<div class="scrollup">
		<a href="#"><img src="images/up.png" alt=""/></a>
	</div>






	<script type="text/javascript" src="js/jquery/jquery.js"></script>

	<script type="text/javascript" src="js/script.js"></script>

	<script type="text/javascript" src="js/bootstrap/bootstrap.min.js"></script>

	<script type="text/javascript" src="js/fancybox/jquery.fancybox.pack.js"></script>

	<script type="text/javascript" src="js/nivo-lightbox/nivo-lightbox.min.js"></script>

	<script type="text/javascript" src="js/owl-carousel/owl.carousel.min.js"></script>





	<script type="text/javascript" src="js/jquery-easing/jquery.easing.1.3.js"></script>
	<script type="text/javascript" src="js/wow/wow.min.js"></script>
	<!--<script type="text/javascript" src="js/counterup/counterup.min.js"></script>-->

	<!--<script src="http://cdnjs.cloudflare.com/ajax/libs/waypoints/2.0.3/waypoints.min.js"></script>-->
	<!--<script type="text/javascript" src="js/counterup/jquery.counterup.min.js"></script>-->


	<script type="text/javascript" src="js/isotop/isotope.min.js"></script>
	<script type="text/javascript" src="js/isotop/isotop.function.js"></script>

	<script type="text/javascript" src="js/masonry/masonry.min.js"></script>

	<script type="text/javascript" src="js/mixitup/jquery.mixitup.min.js"></script>
	<script type="text/javascript" src="js/masonry/masonry.pkgd.min.js"></script>
</body>
</html>
